Uveitis
Managing acute retinal necrosis
This rare disease requires diagnostic vigilance and prompt, effective and—in many cases—long-term treatment in order to be managed properly.
Managing inflammatory CNVM in uveitis
Solving the diagnostic and treatment challenges of choroidal neovascular membrane in uveitis.
Birdshot chorioretinopathy: What’s new
An update on diagnosis and treatment, including the role of multimodal imaging and combination therapy.
Masquerade syndromes in uveitis
A review of neoplastic and nonneoplastic masqueraders that can confound and complicate diagnosis.
Managing UGH syndrome
Uveitis-glaucoma-hyphema syndrome, or Ellingson syndrome, requires surgery targeting the intraocular lens to resolve the cause of chafing.
Treating uveitic macular edema
A review of local and systemic treatments for UME and insights on when to use them.
Uveitis risk of ICPIs for cancer
Immune checkpoint inhibitors are becoming more widely available, but they’ve been linked to uveitis in some patients.
Using anti-VEGF agents in uveitis
A review of the available evidence and anecdotal reports supporting their use.
Retinal implant platforms moving from uveitis to AMD
Treatments show potential for various posterior-segment diseases based on their success treating noninfectious uveitis.
Taking treatment beyond adalimumab
An update on biologic alternatives for ocular inflammatory disease when the approved agent just won’t cut it.
How COVID-19 has altered uveitis management
The pandemic has potentially changed the risk-benefit balance between local therapy and systemic immunosuppression.
Noninfectious uveitis in pregnancy
Knowing the options available for safely treating pregnant patients will empower retina specialists to confidently care for them.
PPV in the management of uveitis
Pars plana vitrectomy can be an important tool in the diagnosis and treatment of uveitic disease in carefully selected patients.
Managing TRC in posterior uveitis
Guidance for detecting and managing toxoplasmosis retinochoroiditis.
When to consider systemic treatments
Scenarios for systemic immunosuppression, and where conventional immunosuppressants and biologics fit in.
Avoid these pitfalls when ordering labs
More testing doesn’t necessarily result in better patient care and can lead to unnecessary lab work.
How OCT is aiding uveitis management
Optical coherence tomography helps grade inflammation and evaluate the vitreous, retinal vasculature and choroid.
Current and new steroid therapy in noninfectious uveitis
Corticosteroid therapy is the cornerstone of treatment. Sustained delivery systems and concomitant use with other medications are expanding options.
Noninfectious Uveitis: Enriching Our Toolbox
Recent advances in localized therapies provide options to traditional systemic immunosuppression.
What’s the Cause of this Panuveitis?
Sensitivity to light, pain and blurry vision persisted for two weeks.
Current Issue
Continuing Medical Education
Additional Publications
Earlier Treatment Can Matter for Macular Edema Following Retinal Vein Occlusion
Sponsored by Regeneron
In pivotal trials, Eylea demonstrated its efficacy as a powerful treatment option for macular edema following RVO.
In pivotal trials, Eylea demonstrated its efficacy as a powerful treatment option for macular edema following RVO.
Treating Chronic Inflammation Associated With Uveitis Affecting the Posterior Segment in a Retina Setting with YUTIQ
GA: Recognizing the Burden
Treatment of Proliferative Diabetic Retinopathy
Improving Wet AMD Outcomes With a Fellow Eye Strategy
Eyepoint Yutiq: A Discussion Among Experts on the Treatment of Uveitis Affecting the Posterior Segment
